Role of cysteine residues in the V(V)-reductase activity of Vanabin2 by Yamamoto, Sohei et al.
広島大学学術情報リポジトリ
Hiroshima University Institutional Repository
Title Role of cysteine residues in the V(V)-reductase activity ofVanabin2
Auther(s) Yamamoto, Sohei; Matsuo, Koichi; Michibata, Hitoshi; Ueki,Tatsuya
Citation Inorganica Chimica Acta , 420 : 47 - 52
Issue Date 2014-08-24
DOI 10.1016/j.ica.2013.11.023
Self DOI
URL http://ir.lib.hiroshima-u.ac.jp/00039968
Right Copyright (c) 2013 Elsevier B.V. All rights reserved.
Relation This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-
nc-nd/4.0/
1 
 1 
 2 
Role of cysteine residues in the V(V)-reductase activity of Vanabin2 3 
 4 
Sohei Yamamoto 1, Koichi Matsuo 2, Hitoshi Michibata 1, Tatsuya Ueki 1,3, * 5 
1 Molecular Physiology Laboratory, Department of Biological Science, and 2 Department of 6 
Mathematical and Life Sciences, Graduate School of Science, Hiroshima University, 1-3-1 7 
Kagamiyama, Higashi-Hiroshima 739-8526, Japan. 3 Marine Biological Laboratory, 8 
Graduate School of Science, Hiroshima University, 2445 Mukaishima, Onomichi, Hiroshima 9 
722-0073, Japan. *Corresponding author: ueki@hiroshima-u.ac.jp TEL: +81-848-44-1434, 10 
FAX: +81-848-44-5914.  11 
 12 
ABSTRACT 13 
   Ascidians (tunicates or sea squirts) accumulate extremely high levels of vanadium as the 14 
reduced form V(III) in extremely acidic vacuoles in their blood cells. Several key proteins 15 
related to vanadium accumulation have been isolated from vanadium-rich ascidians and their 16 
physiological functions characterized. Of these, vanabins are small, cysteine-rich proteins that 17 
have been identified only in vanadium-rich ascidians. Our previous study revealed that 18 
Vanabin2 can act as a V(V)-reductase. The current study examines the role of cysteine and 19 
several other amino acid residues of Vanabin2 in V(V)-reduction. When all eighteen cysteine 20 
residues of Vanabin2 were substituted with serine residues, the V(V)-reductase activity was 21 
lost. Substitutions of three, structurally clustered cysteines in three different regions resulted 22 
in a moderate decrease in reductase activity, suggesting that more than a single cysteine pair is 23 
responsible for the V(V)-reductase activity of Vanabin2. Mutations in the V(IV)-binding 24 
domains caused either an increase or decrease in activity but no mutation caused the complete 25 
2 
loss of activity. These results suggest that some pairs, but more than a single pair, of cysteine 26 
residues are necessary for the V(V)-reductase activity of Vanabin2. 27 
 28 
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1. Introduction 32 
   The unusual ability of ascidians to accumulate high levels of vanadium ions has been 33 
attracting attention in biological and chemical disciplines for a century. The maximum 34 
concentration of vanadium can reach 350 mM in vanadocytes of Ascidia gemmata, belonging 35 
to the class Ascidiidae, which is thought to be the highest metal accumulation of any living 36 
organism [1]. Vanadium usually exists as V(V) in HVO42- or H2VO4- in natural aquatic 37 
environments. These ions are reduced to V(III) via a V(IV) state (VO2+) during assimilation in 38 
ascidians [1, 2]. Vanadium ions are stored in the vacuoles of signet ring cells, which are a type 39 
of blood cell often referred to as vanadocytes (vanadium-accumulating cells) [1]. Ongoing 40 
research during the last two decades has identified many proteins involved in the process of 41 
accumulating and reducing vanadium in vanadocytes, blood plasma, and the digestive tract of 42 
ascidians. Among these, a class of vanadium-binding proteins named vanabins may be 43 
responsible for the selective transport of vanadium. 44 
   Vanabins commonly possess 18 conserved cysteine residues and constitute a unique 45 
protein family present only in vanadium-rich ascidians [3-6]. The most-studied vanabin is 46 
Vanabin2, which has been isolated from Ascidia sydneiensis samea [7, 8, 6]. The 47 
three-dimensional structure of Vanabin2 was determined by NMR spectroscopy, which 48 
revealed eighteen cysteine residues that form nine disulfide (SS) bonds between specific 49 
amino acid residues [7]. Although Vanabin2 was originally isolated as a V(IV)-binding 50 
3 
protein, it adopts an SS/SH intermediate structure and can act as a V(V)-reductase [9]. In 51 
recent experiments, Vanabin2 was shown to act only as a V(V)-reductase [10]. This high 52 
selectivity may account for the metal ion selectivity of vanadium accumulation in ascidians.  53 
   The actual reaction mechanism of Vanabin2 as a V(V)-reductase is still unclear. We 54 
hypothesize the mechanism shown in Scheme 1 [9, 10]. In this redox cascade mechanism, 55 
electrons may be transferred from donor NADPH to acceptor vanadium ions. In turn, 56 
reduction of V(V) to V(IV) can occur via thiol–disulfide exchange reactions with Vanabin2.  57 
According to Scheme 1, one or some of the nine cysteine pairs must be responsible for 58 
V(V)-reduction but it is unclear which cysteine pair(s) is(are) an active site(s). Therefore, this 59 
study examined the contribution of each pair of cysteine residues by site-directed mutagenesis. 60 
In addition, according to another model hypothesizing that V(IV)-binding sites accelerate the 61 
reduction of V(V) [11], we examined the effect of mutagenesis on V(IV)-binding sites. 62 
 63 
2. Experimental Section 64 
2.1 Reagents 65 
   Dithiothreitol (DTT), 2-mercaptoethanol (2-ME), and reduced glutathione (GSH) were 66 
purchased from Wako Pure Chemical Industries. Sodium orthovanadate (Na3VO4; >99.9%) 67 
was purchased from Sigma-Aldrich Co. NADPH and glutathione reductase (GR) were 68 
obtained from the Oriental Yeast Company.  69 
2.2 In vitro site-directed mutagenesis 70 
   Most of the Vanabin2 mutants were synthesized as described previously [11]. The 71 
numbering of amino acid residues was done in accordance with Hamada et al. [7], where 72 
isoleucine, serine, glutamate, and phenylalanine derived from the junction region between the 73 
pMal-c vector and the Vanabin2 cDNA were deemed positions 1–4 (I1–S2–E3–F4). Lysine 74 
(AAA or AAG), arginine (CGN), and histidine (CAT or CAC) residues were substituted with 75 
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alanines (GCN). Cysteine residues (TGT or TGC) were substituted by serines (TCN, AGT or 76 
AGC). Several additional mutants were generated in the same way. Nucleotide sequences 77 
were confirmed using an ABI 3130 automated DNA sequencer (Applied Biosystems Japan 78 
Ltd.) at the Natural Science Center for Basic Research and Development at Hiroshima 79 
University (N-BARD). 80 
2.3 Preparation of recombinant proteins 81 
   Recombinant Vanabin2 protein was prepared in accordance with procedures published 82 
previously [11]. Briefly, the pMAL-c plasmid containing the Vanabin2 coding region [6] was 83 
introduced into Escherichia coli strains TB1, BL21 or KRX. The transformed cells were 84 
incubated in LB medium containing 50 μg/mL ampicillin and 0.5 mM IPTG. The cells were 85 
harvested, re-suspended in a lysis buffer (10 mM Na2HPO4, 30 mM NaCl, 10 mM EDTA, 86 
0.25% Tween 20, 10 mM 2-ME, pH 7.0) containing 4 M urea and then sonicated using a 87 
UH-150 ultrasonic homogenizer (SMT Company). The fusion protein was purified from the 88 
soluble cellular fraction by affinity chromatography using amylose resin in accordance with 89 
the manufacturer’s protocol (New England BioLabs). For further purification, when necessary, 90 
the protein was cleaved at the MBP junction by incubation with Factor Xa and the released 91 
Vanabin2 was purified through an anion-exchange column filled with DEAE-Sephacel resin 92 
(GE Healthcare). The eluted protein was dialyzed four times in 100 volumes of 50 mM 93 
Tris–HCl (pH 7.4) for use in vanadium reductase activity assays. Prior to use, the purity of the 94 
Vanabin2 was confirmed by SDS-PAGE. 95 
2.4. NADPH-coupled oxidation assays 96 
   Metal reductase activity was measured using an NADPH-coupled oxidation assay as 97 
described previously [9]. The assay buffer contained 50 mM Tris-HCl (pH 7.4), 200 μM 98 
NADPH, 0.25 U/mL GR, and 2 mM GSH. With the exception of the negative control tube, 99 
Vanabin2 or the control protein was added to a final concentration of 2 μM in each tube and 100 
5 
the solutions were pre-heated at 20°C for at least 15 min. V(V) stock solution was prepared 101 
by dissolving sodium orthovanadate in ultra-pure water at 10 mM and the pH was adjusted to 102 
7.4. The solution was heated at 65°C until colorless. V(V) was added to the reaction tube to a 103 
final concentration of 2.5 mM. NADPH has a peak absorbance at 340 nm, and its oxidation 104 
coupled with GSH/GSSG can be monitored at this wavelength [12]. NADPH oxidation was 105 
monitored by measuring the solution absorbance at 340 nm for 30 min at 20°C using a 106 
U-2900 spectrophotometer equipped with a thermoelectric cell holder (Hitachi Co. Ltd.).  107 
2.5. Circular dichroism spectrometry 108 
   The secondary structure of Vanabin2 was examined by circular dichroism (CD) 109 
spectroscopy as in a previous study with minor modifications [11]. Prior to CD measurements, 110 
the purity of the protein was confirmed by SDS-PAGE and the protein concentration was 111 
adjusted to 100 µg/mL in 50 mM Tris-HCl buffer (pH 7.4). CD spectra were measured using a 112 
Jasco J720W spectropolarimeter in a 1.0-mm or 10.0-mm pathlength cell at RT with a 1.0-mm 113 
slit, a 4-s time constant, a 100-nm/min scan speed, and 6–10 accumulations. 114 
 115 
3. Results 116 
3.1 Coupled assays for V(V)-reductase activity in Vanabin2 mutants 117 
   According to Scheme 1, disulfide bonds are necessary for the V(V)-reductase activity of 118 
Vanabin2. Vanabin2 possesses nine cysteine pairs that make disulfide bonds, and they are 119 
numbered as per our previous study (SS1 to 9) (Fig. 1). The 3D structure revealed that these 120 
cysteine pairs exist as three spatially dispersed clusters [7]. Therefore, we first created three 121 
disulfide mutants of Vanabin2. Serine was chosen as the substituent because it is structurally 122 
similar to cysteine but contains a hydroxyl (-OH) group in place of the sulfhydryl, or thiol 123 
(-SH) group. SSm1-3 incorporates cysteine-to-serine mutations at SS1, SS2, and SS3. 124 
SSm4-6 and SSm7-9 contain substitutions in SS4 to 6 and SS7 to 9, respectively. 125 
6 
   The reductase activity of the three disulfide mutants was measured and compared to the 126 
reductase activity of wild-type Vanabin2. As shown in Fig. 2, wild-type Vanabin2 produced 127 
18 µmol NADP+ per µmol enzyme in 30 min. Typical absorbance spectra are shown in 128 
Supplementary Fig. 1. This result is reproducible relative to the results of a previous report [9]. 129 
All three disulfide mutants maintained their reductase activity. This indicates that more than a 130 
single disulfide bond is involved in the V(V)-reducing activity of Vanabin2. Furthermore, 131 
SSm1-3 and SSm4-6 mutations exhibited elevated reductase activity over a similar catalytic 132 
time course, but with different catalytic velocities. The possible reason for elevated activity is 133 
discussed below. 134 
   Three additional mutants, K10AR60A, K24AK38AR41AR42A, and H64A, which 135 
contain mutations of V(IV)-binding sites, were also examined [11]. The results are 136 
summarized in Fig. 3, which shows the amount of NADPH oxidation after 30 min under 137 
identical reaction conditions. Similar results for SSm1-3, SSm4-6, and SSm7-9 mutants from 138 
the same experiment are shown in Fig. 2. Bovine serum albumin (BSA) was used as the 139 
negative control. Two of the disulfide mutants, SSm1-3 and SSm4-6, yielded an elevated 140 
reductase activity, while the activity of SSm7-9 did not differ significantly from that of 141 
wild-type Vanabin2. Two of the proteins with mutant V(IV)-binding sites resulted in a slightly 142 
elevated reductase activity, although the H64A mutant did not alter reductase activity. These 143 
results suggest that more than a single cysteine pair is critical for the reductase activity of 144 
Vanabin2. They also indicate that any single V(IV)-binding site may be solely responsible for 145 
V(V)-reductase activity. The possible reason for elevated activity is also discussed below. 146 
   We then examined a mutant lacking all nine pairs of disulfide bonds (SSm1-9). Since this 147 
mutant protein in easily degraded after removing the carrier MBP, MBP fusion proteins were 148 
used in these assays. As a comparison, wild-type Vanabin2 was also fused to MBP. MBP itself 149 
was used as a control.  150 
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   The V(V)-reductase activity of the Vanabin2-MBP fusion protein did not differ 151 
significantly from that of Vanabin2 itself (Figs. 3 and 4). MBP, as a negative control, gave a 152 
low but significant reductase activity in this assay system, reaching an activity about twice 153 
that of the control reaction without MBP. The SSm1-9 mutant fused with MBP yielded a 154 
decreased (V)-reductase activity level not significantly different from that of the MBP control. 155 
Thus, Vanabin2 lacking cysteine residues could not reduce V(V), which supports the cascade 156 
mechanism shown in Scheme 1. 157 
3.2 Secondary structure of SSm1-9 mutant Vanabin2 158 
   Since the artificial mutations described above might affect the overall protein structure, 159 
the effects of mutations on the secondary structure of Vanabin2 were examined by CD 160 
spectroscopy. In these assays, wild-type Vanabin2 and SSm1-9 mutants were prepared 161 
separate from the carrier MBP protein. The purity of this wild-type Vanabin2 was almost 162 
100%. The SSm1-9 mutant was a mixture of 70% full-length segments with the remainder of 163 
shorter fragments.  164 
   Fig. 5A shows the CD spectra of wild-type Vanabin2 and the SSm1-9 mutant in 50 mM 165 
Tris-HCl buffer (pH 7.4). In this wavelength range, the CD spectra indicated the presence of 166 
α-helices and β-sheets. The spectra were normalized to the ellipticity at 222 nm. These 167 
spectra suggest that the secondary structure of SSm1-9 was not significantly altered from that 168 
of wild-type Vanabin2. 169 
   The peak at 270–260 nm in the CD spectra of Vanabin2 is a good indicator of the reduced 170 
state of the disulfide bonds in Vanabin2 [9]. CD spectra were also acquired for the SSm1-9 171 
mutant, which lacks all of the native SS bonds. Fig. 5B shows the CD spectra of wild-type 172 
Vanabin2 and the SSm1-9 mutant in the absence of reducing agents. The data show that 173 
wild-type Vanabin2 formed SS-bonds while SSm1-9 completely lacked SS-bonds. Thus, the 174 
8 
SSm1-9 mutant retained the secondary structure of the wild-type protein but lost its 175 
V(V)-reductase activity due to the loss of SS-bonds.  176 
 177 
4. Discussion 178 
Vanabin2, a vanadium-binding protein isolated from the cytoplasm of vanadocytes, acts as a 179 
V(V)-reductase [9]. As of yet, Vanabin2 has been reported as only a V(V)-reductase [10]. In 180 
the reaction cascade shown in Scheme 1, the disulfide bond is important for the reduction of 181 
V(V). Vanabin2 contains nine disulfide bonds [7] that are thought to be important for its 182 
reductase activity. In this study, we examined the contribution of cysteine and several other 183 
amino acid residues to the V(V)-reductase activity of Vanabin2. The first series of mutants, 184 
SSm1-3, SSm4-6, and SSm7-9, lacked three of the nine cysteine pairs and retained reductase 185 
activity. In contrast, the SSm1-9 mutant, which lacked all nine cysteine pairs, lost all 186 
reductase activity. These results suggest that cysteine pairs are indispensable in the 187 
V(V)-reductase activity of Vanabin2 but that more than a single pair of cysteine residues is 188 
responsible for the activity. 189 
   In some of mutants for cysteines and vanadium-binding sites, reductase activity was 190 
significantly elevated (Figs. 2 and 3). This was controversy to our expectation that reductase 191 
activity must be decreased by amino acid substitution. Generally, disulfide bridges play an 192 
important role in the construction of the tertiary structure of proteins. Most proteins 193 
containing disulfide bridges unfold when they are completely reduced even in the absence of 194 
a denaturant [13, 14]. In case of Vanabin2, the nine disulfide bridges maintain its rigid 195 
structure as supposed from the NMR study [7], but the SSm1-9 mutant that lacks all disulfide 196 
bonds retains some secondary structures as suggested from the CD spectrum of Fig 5A. 197 
Although we need further experimental evidences about the structure-function relationships of 198 
Vanabin2, these findings indicate the reductase activity would be complicatedly affected by 199 
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the secondary structure and structural flexibility around the reductase reaction sites. 200 
 201 
4.1 Role of cysteine residues in the reductase activity of Vanabin2 202 
   Thiol–disulfide exchange reactions are involved in many cellular activities, such as 203 
protein folding and unfolding [15], maintenance of redox potentials [16], activation of 204 
oxygen-sensitive transcription factors [17], and metal transfer from metalloproteins to 205 
metal-depleted enzymes (metallochaperone activity) [18] in a manner analogous to 206 
phosphorylation/dephosphorylation reactions catalyzed by protein kinases and phosphatases. 207 
In our model system, thiol/disulfide exchange reactions link the reducing agent NADPH to 208 
the V(V)-reductase activity of Vanabin2. In this model, the free thiols of Vanabin2 reduce 209 
V(V) by direct electron transfer. 210 
   The direct involvement of disulfide bonds in metal redox reactions is not often reported. 211 
Electron transfer has been observed between protein thiols and metal ions such as Cu2+ and 212 
Fe3+. The reduction of metallothionine by a heme protein, cytochrome c, is thought to occur 213 
through a direct electron transfer from iron to cysteine [19], while other cysteine oxidation 214 
pathways in the presence of metal ions involve radical species. Cysteine residues are 215 
particularly susceptible to reactive oxygen species, such as superoxide and hydrogen peroxide, 216 
generated in the presence of redox-active metal ions. As observed by Crans [20] and 217 
discussed in our recent paper [10], V(V) cannot be reduced to V(IV) (E0 = −0.341 V) by thiol 218 
compounds whose reduction potentials (E0 ∼ −0.26 V) are higher than that of the V(V)/V(IV) 219 
redox couple. However, specific interactions between thiols and V(V)/V(IV) can occur under 220 
physiological conditions [10, 20]. It is therefore necessary to show whether the reduction of 221 
V(V) to V(IV) in our model system occurs via direct or indirect reaction between thiols and 222 
vanadium ions. 223 
   Vanabin2 reduces vanadate anions (VO43-; V(V)) to vanadyl cations (VO2+; V(IV)). 224 
10 
Arsenate reductases are interesting in that their substrates are also anions (AsO43-; As(V)) and 225 
it is meaningful to compare the relative properties of these two systems. E. coli ArsC and S. 226 
cerevisiae Acr2p have been identified earlier and investigated extensively [21]. The only 227 
substrate of E. coli ArsC was arsenate (Km=0.8 mM) with a Vmax that typically ranges from 0.8 228 
to 1.5 pmol/min/mg protein[22]. A recent study on Synechocystis ArsC revealed a Vmax of 3.1 229 
µmol/min/mg protein[23]. The latter value corresponds to 45 mol/min/mol of ArsC, which is 230 
about 40-fold greater than that of wild-type Vanabin2 (1.15 mol/min/mol protein) [9]. ArsC 231 
has a single catalytic cysteine residue [24], while Synechocystis ArsC contains three essential 232 
cysteine residues [23]. The position of the catalytic cysteine residue is to be determined in a 233 
future study. 234 
4.3 Possible in vivo reduction cascade  235 
   In the ascidian A. sydneiensis samea, the Vanabin family consists of at least five closely 236 
related proteins, Vanabins 1–4 and VanabinP. Vanabins 1–4 are expressed in the cytoplasm of 237 
vanadocytes, while VanabinP is in blood plasma [25, 3]. All five of these Vanabins possess 18 238 
cysteine residues; the intervals between these cysteines are very well conserved. Vanabin1 239 
and Vanabin4 can also reduce V(V) to V(IV) (unpublished data). Therefore, it is possible that 240 
four cytoplasmic vanabins act together to reduce V(V) to V(IV). Since the concentration of 241 
GSH is 1.83 mM in the vanadocytes of A. sydneiensis samea, and the enzymes involved in the 242 
pentose phosphate pathway are expressed exclusively in the cytoplasm of these vanadocytes, 243 
the existence of a redox cascade from NADPH to V(V) ions in the cytoplasm of vanadocytes 244 
is likely. 245 
4.4 Detoxification or energy source? 246 
   In our model, V(V) ions are readily reduced to V(IV) in the cytoplasm, V(IV) ions are 247 
stabilized by Vanabins, and a proton electrochemical gradient generated by vacuolar 248 
H+-ATPase (V-ATPase) gives the driving force for V(IV) transport from the cytoplasm into 249 
11 
the vacuole using the V(IV)/H+ antiporter, AsNramp [26]. Export of stored vanadium out of 250 
the vacuole has not been reported to date. 251 
   It is usually accepted that vanadium toxicity increases with an increasing oxidation state, 252 
with V(V) being the most toxic. Vanadate also inhibits ATPases because vanadate and 253 
phosphate are structurally similar [27]. V(IV) should be toxic to cellular components because 254 
it can cause Fenton reactions, which produce reactive oxygen species [28]. Storage of V(III) 255 
in an acidic vacuole is, therefore, an appropriate strategy for storing high concentrations of 256 
vanadium. 257 
   Considering the cost of maintaining such high levels of vanadium, which often reach up to 258 
107 times higher than that in sea water, vanadium accumulation must benefit ascidians. One 259 
should therefore consider whether the reverse reactions, accompanying the oxidations of 260 
V(III) to V(IV) and V(IV) to V(V), occur in the proposed cascade, perhaps resulting in the 261 
release of energy as in a vanadium redox flow battery. Thus, another possibility is that 262 
ascidians may accumulate metal ions as an energy source. 263 
 264 
5. Conclusions 265 
   Vanabin2 contains nine disulfide bonds. When all of these disulfide bonds were removed 266 
by site-directed mutagenesis, the resulting SSm1-9 mutant lost its V(V)-reductase activity. 267 
Three partial mutants, SSm1-3, SSm4-6, and SSm7-9, which lack three of the nine cysteine 268 
pairs, retained their reductase activity. These results suggest that cysteine pairs are 269 
indispensable in the V(V)-reductase activity of Vanabin2, but that more than a single pair of 270 
cysteines is required. In contrast, all V(IV)-binding site mutants examined retained their 271 
reductase activity. Thus, V(IV)-binding sites are not required for the reductase activity of 272 
Vanabin2. 273 
 274 
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Figure legends 334 
 335 
 336 
Scheme 1. A proposed redox cascade mechanism for the V(V) reductase activity of Vanabin2. 337 
 338 
339 
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 340 
Fig. 1. The three-dimensional structure of Vanabin2 is shown with mutation sites as indicated. 341 
(A) The ribbon model of Vanabin2 shows nine cysteine pairs (SS1–9). (B) The spherical 342 
model of Vanabin2 shows possible VO2+-binding sites in light gray and are denoted by amino 343 
acid numbers on the two faces, looking in opposite directions [7]. PDB data (ID: 1vfi) were 344 
used to compute these structures, which included the four additional amino acids (I–S–E–F) 345 
originating from the junction region of the pMal-c vector. PyMol software was used to 346 
generate the spherical images. Images were modified from our previous work [11]. 347 
 348 
349 
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 350 
Fig. 2. The reductase activities of wild-type and disulfide mutants of Vanabin2 are shown as a 351 
function of time. Representative results are given for (A) wild-type Vanabin2 and (B) SSm1-3, 352 
(C) SSm4-6 and (D) SSm7-9 mutants of Vanabin2. The solid line with solid circles 353 
corresponds to the activity of 2 μM wild-type or mutant Vanabin2. The dotted line with open 354 
circles corresponds to the activity without Vanabin2. The horizontal axis indicates the time 355 
after the initiation of catalysis. The vertical axis indicates the amount of NADPH oxidation. 356 
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 359 
Fig. 3. The reductase activities of wild-type, disulfide mutants, and V(IV)-binding-site 360 
mutants of Vanabin2 are shown. WT and BSA correspond to wild-type Vanabin2 and bovine 361 
serum albumin, respectively. SSm1-3, SSm4-6, and SSm7-9 correspond to disulfide mutants 362 
of Vanabin2. K10AR60A, K24AK38AR41AR42A, and H64A contain mutations in 363 
V(IV)-binding sites. The vertical axis indicates the amount of NADPH oxidation after 30 min 364 
under the same reactions conditions as those used in Fig. 2. Open bars indicate the values for 365 
experiments including each protein at a concentration of 2 µM. Gray bars indicate negative 366 
controls excluding each protein. BSA was included as a negative control.  367 
 368 
369 
19 
 370 
Fig. 4. The reductase activity of wild-type and mutants of Vanabin2, including the activity of 371 
maltose-binding protein (MBP), is shown. WT corresponds to wild-type Vanabin2. SSm1-9 is 372 
the mutant Vanabin2 with serine residues replacing all of the native cysteine residues. MBP 373 
was used as a negative control. The vertical axis indicates the amount of NADPH oxidation 374 
after 30 min using the same conditions used to generate the data in Fig. 2. Open bars indicate 375 
values obtained with each protein at a concentration of 2 µM. Gray bars indicate data 376 
obtained with the negative controls. 377 
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Fig. 5. CD spectra of wild-type (WT) Vanabin2 and the SSm1-9 mutant. CD spectra were 382 
measured in 50 mM Tris-HCl buffer (pH 7.4) at 20°C for WT Vanabin2 (solid line) and the 383 
SSm1-9 mutant (dotted line). (A) The secondary structure of wild-type and mutant Vanabin2. 384 
The spectra were normalized to the ellipticity at 222 nm. No significant changes to the 385 
secondary structure were induced by the mutation. (B) Disulfide bond formation as observed 386 
by CD spectroscopy. A peak between 270 and 260 nm was observed with fully oxidized 387 
Vanabin2. In contrast, this peak was not observed in the CD spectrum of the SSm1-9 mutant. 388 
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